Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


ESMO Sarcoma & GIST 2020 will follow a new format comprising back-to-back events

Access the online programme

Preceptorship Course: Monday, 3 February 2020

Half-day meeting designed to provide young oncologists with a brief outline of both STS & GIST. It could be a first contact with these diseases for oncologists who are interested to know more about them and to have an introduction to the high-profile Conference in the two days afterwards.

Advanced Course: Monday, 3 February 2020

Half-day event offering an intensive discussion of a set of clinical cases of STS & GIST for professionals who are already familiar with these diseases. Attendees will benefit from discussions about challenging clinical cases with specialists from both the EU and USA, leveraging the different perspectives and expertise across continents. This course is the ideal preparation for clinicians joining the Sarcoma & GIST Conference, 3-5 February.

Main Symposium: Monday-Wednesday, 3-5 February 2020

The goal is to merge the clinical and the translational perspectives into a single high-profile educational event. It is a unique opportunity in rare cancers such as STS & GIST.  The Conference is known as an excellent place for international networking and collaboration, featuring discussions with the key opinion leaders in the field.

Though it will be deeply and convincingly multidisciplinary as all previous editions, the 2020 programme will look at the disciplines, one by one. The challenge, in fact, will be to do so with a multidisciplinary attitude and preserving the biological/clinical integration which marks this event. A world-renowned faculty will attract an audience of experts in sarcomas, but will also teach a lot to oncologists mainly dealing with more frequent conditions while also treating sarcomas within collaborative networks.


ESMO-MORA: The ESMO Sarcoma & GIST Symposium 3-5 February 2020, Milan has been accredited with 24 cat.1 ESMO-MORA points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. Learn more about ESMO-MORA recertification.


The Main Symposium webcasts will include all the session of the official programme, where speaker permission is granted, and will be available here and on OncologyPRO for ESMO Members.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings